Lymphoproliferative tumors in rheumatic diseases

Lymphoproliferative tumors in rheumatic diseases

The development of lymphoid tumors in patients with rheumatic diseases can significantly worsen the quality of life and negatively affect the prognosis. The article presents modern data on the relationship between lymphoid tumors and rheumatic diseases. Practical differential diagnosis guidelines of...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. R. Gorodetskiy, I. V. Poddubnaya, E. L. Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2024-12-01
Series:	Научно-практическая ревматология
Subjects:	lymphoid tumor rheumatic disease t cell large granular lymphocytic leukemia felty’s syndrome diffuse large b cell lymphoma pathogenesis
Online Access:	https://rsp.mediar-press.net/rsp/article/view/3652
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neutropenia in rheumatoid arthritis and large granular lymphocyte leucosis
by: V A Doronin, et al.
Published: (2003-02-01)

Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies
by: Allison M. Bock, et al.
Published: (2025-07-01)

Analysis of clinical and laboratory characteristics of six cases with T-cell large granular lymphocytic leukemia
by: LU Hongyu, LIU Hong, SONG Luxi
Published: (2024-12-01)

Difficulties of lymphoid neoplasia diagnosis in patients with rheumatoid arthritis
by: V R Gorodetsky, et al.
Published: (2009-06-01)

Revisiting and demystifying primary and secondary renal lymphoma: A series of two cases
by: Kaustubh Gupta, MD, et al.
Published: (2025-10-01)

Laparoscopic distal gastrectomy for synchronous adenocarcinoma, diffuse large B cell lymphoma and gastrointestinal stromal tumor in the stomach: a case report
by: Toshiyasu Ojima, et al.
Published: (2022-05-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

Predictive levels of vascular endothelial growth factor (VEGF), thymidine kinase 1 (TK1) with interleukin-6 (IL-6), plasma T cells, NK cells as well as B cells in treating diffuse large B-cell lymphoma receiving rituximab
by: Tian Lihua, et al.
Published: (2025-01-01)

Non-Hodgkin’s Lymphomas in Children: 25-Year Clinical Experience
by: TT Valiev, et al.
Published: (2016-10-01)

Golidocitinib was used for the first time to treat refractory NK-Large Granular lymphocytic leukemia with a STAT3 mutation, accompanied by hemolytic anemia: a case report
by: Hongyuan Hao, et al.
Published: (2025-08-01)

Management of Diffuse Large B-Cell Lymphoma as Post-Transplant Lymphoproliferative Disorder in a Kidney Transplant Recipient: A Case Report
by: Salem Alshemmari, et al.
Published: (2025-04-01)

Testicular diffuse large B-cell lymphoma. Clinical lecture and case report
by: K. B. Lelyavin, et al.
Published: (2023-12-01)

High oxidative phosphorylation represented by UQCRFS1 marks CD8 + tumor-infiltrating lymphocytes exhaustion in diffuse large B-cell lymphoma
by: Yiming Yang, et al.
Published: (2025-08-01)

A randomized, multiple-dose, multicenter, comparative parallel study to evaluate the safety and efficacy of intravenous infusion of rituximab (Hetero) and reference medicinal product (Rituximab, Roche) in Indian patients of non-hodgkin's lymphoma (HERILY)
by: Suresh Advani, et al.
Published: (2018-01-01)

Intensive polychemotherapy efficacy in young adults with diffuse B-large cells lymphoma from germinal center cells
by: M. M. Bobkova, et al.
Published: (2022-11-01)

Treatment of central nervous system lymphoma — literature review and own experiences
by: S. V. Minenko, et al.
Published: (2014-07-01)

Nutritional deficiency in patients with newly diagnosed diffuse large B-cell lymphoma Prevalence and approaches to correction
by: O. A. Obukhova, et al.
Published: (2024-09-01)

Heterogeneous characteristics of γδ T cells in peripheral blood of diffuse large B-cell lymphoma
by: Peng-Lin Wang, et al.
Published: (2025-06-01)

Recurrent primary pulmonary anaplastic B-cell lymphoma in a 35-year-old patient treated with radical resection: A case report.
by: George Bashour, et al.
Published: (2025-03-01)

VSIG4 as a tumor-associated macrophage marker predicting adverse prognosis in diffuse large B-cell lymphoma
by: Dongshen Ma, et al.
Published: (2025-06-01)

Oral Manifestations of T-Cell Large Granular Lymphocytic Leukemia: a Case Report
by: Ioanna-Eirini Arvanitidou, et al.
Published: (2011-06-01)

Lymphocyte/monocyte to lactate dehydrogenase ratio prior to lymphodepletion impact the outcomes of patients with diffused large B cell lymphoma undergoing CAR-T cell therapy
by: Na Li, et al.
Published: (2025-03-01)

Current trends in pediatric aggressive B-cell lymphomas treatment
by: Yu. S. Korkina, et al.
Published: (2021-06-01)

Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review
by: M. A. Mingalimov, et al.
Published: (2024-04-01)

Single-cell RNA sequencing in diffuse large B-cell lymphoma: tumor heterogeneity, microenvironment, resistance, and prognostic markers
by: Linwei Li, et al.
Published: (2025-04-01)

Primary lymphatic tumors of bones: two case reports and a review of literature
by: E. K. Egorova, et al.
Published: (2022-11-01)

Case Presentation: Large Diffuse B-cell Lymphoma Developing in the Context of Primary Immunodeficiency
by: Hikmet Gülşah Tanyıldız, et al.
Published: (2024-12-01)

A Case of a Rapidly Progressive Small Bowel Lymphoma with High Ki-67 Expression
by: Jiyeon Yoo, et al.
Published: (2017-03-01)

Clinical characteristics and treatment evaluation of diffuse large B-cell lymphoma in Chinese children and adolescents: a multicenter clinical study of China-Net childhood lymphoma group B-NHL-2017
by: Yang Fu, et al.
Published: (2025-07-01)

Correlations Between Immunophenotypic Markers and Clinical Progression in Romanian Patients Diagnosed with Diffuse Large B-Cell Lymphoma
by: Georgian Halcu, et al.
Published: (2025-05-01)

The first-line therapy of aggressive non-Hodgkin’s lymphomas in russian clinical practice: data from the EQUILIBRIUM study
by: L. G. Babicheva, et al.
Published: (2020-07-01)

Diffuse large B-cells lymphoma clinical features in patients with hepatitis B and C infection
by: G. I. Storozhakov, et al.
Published: (2022-11-01)

Upregulation of stomatin is associated with poor prognosis and promotes tumor progression of orbital diffuse large B-cell lymphoma
by: Wen Chen, et al.
Published: (2025-05-01)

Primary diffuse cutaneous large B-cell lymphoma, anaplastic type
by: S. V. Antonyuk, et al.
Published: (2012-04-01)

The role of рАКТ1 expression in diffuse large B-cell lymphoma
by: E. V. Vaneeva, et al.
Published: (2021-10-01)

Primary Diffuse Large B-Cell Lymphoma of the Adrenal Glands: a Rare Cause of Paraneoplastic Neuropathy
by: D. V. Shestakov, et al.
Published: (2024-10-01)

Circulating mucosa-associated invariant T cells are decreased and have impaired function in patients with diffuse large B-cell lymphoma
by: Jingru Liu, et al.
Published: (2025-09-01)

Transformed diffuse large B-cell lymphoma of the stomach in a patient with Sjögren's disease and systemic sclerosis: case report and literature review
by: V. I. Vasiliev, et al.
Published: (2022-12-01)

Primary Mediastinal Large B-cell Lymphoma – A Case Report
by: Bruno Pelinson Fogaça Duarte, et al.
Published: (2024-01-01)

Diffuse Large B‐Cell Lymphoma With Membranous Proliferative Glomerulonephritis as the First Manifestation: A Case Report
by: Hongrui Xiao, et al.
Published: (2025-04-01)